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ABSTRACT
Background: Although the association between asthma control and body mass index (BMI) has been thor-
oughly investigated, most of this work has focused on the influence on asthma incidence or the effect of obesity
on asthma control. To date, there have been no published studies on the influence of underweight on asthma
control.
Methods: The aim of this study was to investigate the influence of underweight, as defined by the Japan Soci-
ety for the Study of Obesity (JASSO), on asthma control in Japanese asthmatic patients. Using data from ques-
tionnaire surveys administered by the Niigata Asthma Treatment Study Group, we compared asthma control,
as measured by the Asthma Control Test (ACT), between a normal weight group (18.5 kgm2 =< BMI < 25 kg
m2) and an underweight group (BMI < 18.5 kgm2).
Results: Of the asthmatic patients who completed the 2008 and 2010 surveys, 1464 and 1260 cases were
classified as being in the normal weight group, and 174 and 155 cases were classified as being in the under-
weight group. The ACT score (median, [interquartile range]) in the underweight group in 2008 (22, [19-24]) and
2010 (23, [19-25]) was significantly lower than that in the normal group in 2008 (23, [20-25]) and in 2010 (24,
[21-25]).
Conclusions: This study is the first, large-scale investigation of the influence of underweight on asthma con-
trol, and we have confirmed an adverse influence in a clinical setting. A potential mechanism for this interaction
was unknown. Further investigation will be required.
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ABBREVIATIONS
ACT, asthma control test; AIA, aspirin intolerant asthma; BMI, body mass index; ED, emergency department;
ICS, inhaled corticosteroid; IQR, interquartile range; JASSO, Japan Society for the Study of Obesity.
INTRODUCTION
The widespread use of inhaled corticosteroids (ICS)
in the clinical setting has resulted in vast improve-
ments in asthma control.1-3 However, asthma preva-
lence and mortality are not low, leading to an esti-
mated annual loss of 15 million disability-adjusted life
years, according to the World Health Organization.4
Asthma imposes a considerable social and economic
burden and needs to be addressed urgently.5,6 This
includes measures to further improve asthma man-
agement.
An increasing body of literature suggests an inter-
action between body mass index (BMI) and asthma.7
Epidemiologic studies have suggested that over-
weight and obesity increase asthma incidence and
skew prevalent asthma towards a more difficult-to-
control phenotype.8-13 However, there are very few
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reports on the association between being under-
weight and asthma. Almost all of these studies fo-
cused on the influence of underweight on asthma in-
cidence, both in children and adults.14-20 Therefore, it
remains uncertain whether underweight can influ-
ence the control of asthma in the same way as over-
weight or obesity.
This study used the regular questionnaire survey
administered by the Niigata Asthma Treatment Study
Group since 1998. This survey includes questions re-
lating to asthma management. The subjects in this
survey were adult patients with bronchial asthma
who visited medical institutions in Niigata Prefecture.
The attending physicians of these patients were in-
cluded in the survey. On the basis of these surveys,
we have previously reported the clinical characteris-
tics of adult bronchial asthma patients,21 elderly bron-
chial asthma,22 near-fatal asthma,23 and perimenstrual
asthma.24 We have also published results relating to
exacerbation factors,25 the selection of ICS,26 the rela-
tionship between smoking and gender in asthmat-
ics,27 and changes in asthma management.1-3 These
surveys give a good indication of the actual state of
asthma management in Japan. In this study, we at-
tempted to analyze the influence of underweight on
asthma control in Japanese asthmatic patients using
the data from 2008 and 2010 surveys. We classified
patients with asthma into a normal weight group and
an underweight group. As the definitions of under-
weight, normal and obese, can vary by race,28-31 we
used the JASSO BMI definitions for this study.
METHODS
Participation in this study was open to all medical in-
stitutions in Niigata Prefecture who intended to join
the Niigata Asthma Treatment Study Group. This
study was performed with the approval of the Ethics
Committee of the School of Medicine of Niigata Uni-
versity in Niigata Prefecture, Japan, or at the relevant
participating institution, in accordance with the Ethi-
cal Principles for Medical Research Involving Human
Subjects (Declaration of Helsinki). The surveys from
2008 and 2010 involved 28 and 24 large hospitals (200
beds or more), 14 and 16 small hospitals (less than
200 beds), and 62 and 56 clinics (no beds), respec-
tively. In the 2008 and 2010 surveys, a total of 5260
and 4662 questionnaires were prepared, and 3146 and
2762 responses were received (response rate: 59.8
and 59.2%), respectively. Table 1 shows the questions
used in the questionnaire (originally in Japanese).
The survey was performed over 2 months from Sep-
tember to October in 2008 and 2010. Subjects were
adult patients (aged 16 years or older) with bronchial
asthma who regularly visited the participating institu-
tions for asthma management (typically once or twice
per month). The recruited patients were asked to
complete the questionnaire by themselves. There-
fore, individual patients were expected to understand
technical terms such as “attack” or “unconscious-
ness” in the questionnaire (Table 1). In addition to
this questionnaire, the Asthma Control Test (ACT),
which has been validated as a clinical indicator of
asthma control,32,33 was carried out separately at the
same time. To evaluate problems with asthma man-
agement and treatment related to normal activity lev-
els, the questionnaires also asked patients about their
satisfaction with daily life. The subjects answered by
choosing 1 of 5 answers, as shown in Table 1.
In addition to monitoring their patients’ completion
of the questionnaire, physicians were asked to supply
details on current treatment, in particular the medica-
tions used for control, the type of asthma (atopic or
non-atopic) in accordance with elevation in serum to-
tal IgE or detection of specific IgE for allergens, and
the severity of asthma in accordance with Asthma
Prevention and Management Guideline 2006 (in Japa-
nese) published by Japanese Society of Allergology
(JSA). This definition of asthma severity is essentially
the same as that used by the Global Initiative for
Asthma 2006.
The results for continuous variables were ex-
pressed as arithmetic means and standard deviations.
Intergroup differences in terms of continuous vari-
ables were evaluated using the Kruskal-Wallis test
and Wilcoxon’s rank sum test with the Bonferroni
correction. A Chi-square test with the Bonferroni cor-
rection was also used to assess the significance of dif-
ferences in proportions between groups. All statistical
analyses were performed with the statistical software
StatView 5.0 PowerPC version (SAS Institute Inc.,
Cary, NC, USA). For all statistical analyses, a P-value
< 0.05 was considered to be significant.
RESULTS
PATIENT CHARACTERISTICS
The characteristics of patients completing the 2008
and 2010 surveys are summarized in Table 2A, B, re-
spectively. Of the asthmatic patients who answered
the questionnaire in 2008 and 2010, 1464 and 1260
were classified as being in the normal weight group
(18.5 kgm2 BMI < 25 kgm2) and 174 and 155
were classified as being in the underweight group
(BMI < 18.5 kgm2), respectively. The mean BMIs of
the underweight groups in the 2008 and 2010 surveys
were significantly lower (17.4+-0.9 kgm2, 17.4+-0.9
kgm2) than those of the normal weight groups (21.7
+-1.8 kgm2, 21.9+-1.8 kgm2). In the 2010 survey,
there were significantly more females in the under-
weight group than in the normal group. There were
no significant differences in age, disease duration,
disease type, smoking status, the rate of peak-flow
meter use and disease severity between the normal
and underweight groups in either survey.
ASTHMA SYMPTOMS AND CONTROL
The ACT scores (median, interquartile range [IQR])
Effect of Underweight on Asthma Control
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Table　1　Questionnaire administered to asthmatic patients (original in Japanese)
Age:          years old          Gender: male/female
Question 1
When were you fi rst diagnosed as having bronchial asthma? Year:    Month:    Day:
Question 2
1) Select which of the following applies to you:
(I do not smoke, I am an ex-smoker, I currently smoke)
2) If you are an ex-smoker, please answer followings:
At what age did you start smoking? The age you started:
At what age did you stop smoking? The age you stopped:
How many cigarettes did you smoke per day? Cigarettes/day (on average):
Did you stop smoking due to your asthma? Yes or No:
3) If you currently smoke, please answer the following:
How old were you when you started smoking? The age you started:
How many cigarettes did you smoke per day? Cigarettes/day (on average):
Question 3
1) Do you use a peak-fl ow meter? (Yes or No)
2) What was your average peak fl ow rate when using your meter during the last 2 weeks?
Morning:                                Night:
Question 4   Select one answer for each the following questions:
1) How often did you have asthma attacks during the last 12 months?
(frequent attacks, seasonal attacks, or few attacks)
2) How often did you have asthma attacks during the last 2 weeks?
(5-7/week, 3-4/week, 1-2/week, or none)
3) How severe were your asthma attacks during the last 2 weeks?
(impossible to move, impossible to lie down, possible to lie down, stridor, dyspnea upon exertion)
4) Have you ever been hospitalized due to asthma?
(yes/no)
5) Have you ever been taken by ambulance or visited an emergency room due to an attack?
(yes/no)
6) Have you ever been placed on a respirator due to an asthma attack?
(yes/no)
7) Have you ever been unconscious due to an asthma attack?
(yes/no)
8) Have you ever had an attack induced by anti-infl ammatory drugs, including painkillers, antipyretics, or cold medicine?
9) Were you absent from work or school due to an asthma attack during the last 12 months?
(yes/no)
Question 5
How bad was your asthma during the last 2 weeks?
(very good, fairly good, mediocre, slightly bad, or bad)
Question 6
Describe your symptoms during the last 2 weeks:
1) In the morning
(cough, sputa, chest tightness, stridor, dyspnea, or no symptoms)
2) At night
(cough, sputa, chest tightness, stridor, dyspnea, or no symptoms)
3) Sleep disturbance
(sometimes cannot fall asleep due to dyspnea, cannot have a good sleep due to dyspnea, waking up in the night due 
to chest tightness, or none)
Question 7
Do you feel satisfi ed with your daily life?
(very satisfi ed, fairly satisfi ed, mediocre, slightly dissatisfi ed, or dissatisfi ed)
Furukawa T et al.
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Table　2A　Patient characteristics in 2008 survey
Table　2B　Patient characteristics in 2010 survey
Normal group Underweight group
BMI (mean +/- SD: kg/m2) 21.7 +/- 1.8 (N = 1464) 17.4 +/- 0.9*** (174)
Age (mean +/- SD: year) 55.1 +/- 17.4 (N = 1460) 55.2 +/- 20.4 (N = 173)
Gender: male/female (%) 45.4/53.6 (N = 1449) 40.8/59.2 (N = 174)
Duration (mean +/- SD: year) 14.0 +/- 13.5 (N = 1316) 14.3 +/- 13.0 (N = 159)
Type: atopic/non-atopic (%) 69.8/24.4 (N = 1379) 66.1/28.7 (N = 165)
Severity: Step1/2/3/4 (%) 26.8/28.3/25.8/4.7 (N = 1253) 24.7/28.7/21.3/4.0 (N = 147)
Smoking status: Non/Ex/Cu (%) 50.2/31.1/15.7 (N = 1421) 51.7/28.1/16.1 (N = 167)
PEF use rate (%) 26.3 33.3
***P < 0.001 v.s. normal group. Non, non-smoker; Ex, ex-smoker; Cu, current smoker; PEF, peak fl ow meter.
Normal group Underweight group
BMI (mean +/- SD: kg/m2) 21.9 +/- 1.8 (N = 1260) 17.4 +/- 0.9*** (N = 155)
Age (mean +/- SD: year) 56.7 +/- 16.7 (N = 1249) 54.5 +/- 18.7 (N = 153)
Gender: male/female (%) 45.3/53.3 (N = 1242) 25.8/72.9*** (N = 153)
Duration (mean +/- SD: year) 16.2 +/- 15.1 (N = 1137) 13.9 +/- 13.7 (N = 139)
Type: atopic/non-atopic (%) 70.6/24.6 (N = 1200) 64.5/27.7 (N = 144)
Severity: MdI/MdP/MoP/SP/SrP (%) 31.8/24.4/32.1/6.6/1.0 (1210) 25.2/32.3/29.7/5.2/1.9 (N = 146)
Smoking status: Non/Ex/Cu (%) 49.9/33.5/14.7 (N = 1236) 58.7/24.5/14.8 (N = 152)
PEF use rate (%) 23.2 25.2
***P < 0.001 v.s. normal group. MdI, mild intermittent; MdP, mild persistent; MoP, moderate persistent; SP, severe persistent; SrP, sever-
er persistent; Non, non-smoker; Ex, ex-smoker; Cu, current smoker; PEF, peak fl ow meter.
Table　3A　ACT score, asthma attack rate, rates of asthma-related symptoms in morning and night, and the sleep disturbance 
rate during the two weeks prior to answering the survey in 2008
Table　3B　ACT score, asthma attack rate, rates of asthma-related symptoms in morning and night, and the sleep disturbance 
rate during the two weeks prior to answering the survey in 2010
Normal group (N = 1464) Underweight group (N = 174)
ACT (median [IQR]) 23 [20-25] 22 [19-24]*
Asthma attack rate (%) 22.5 26.5
ARS in morning rate (%) 41.7 44.3
ARS in night rate (%) 29.8 35.1
Sleep disturbance rate (%) 13.7 15.5
*P < 0.05 v.s. normal group. ARS, asthma-related symptoms; IQR, interquartile range.
Normal group (N = 1260) Underweight group (N = 155)
ACT (median [IQR]) 24 [21-25] 23 [19-25]*
Asthma attack rate (%) 18.4 23.9
ARS in morning rate (%) 38.3 43.9
ARS in night rate (%) 27.5 31.0
Sleep disturbance rate (%) 10.9 16.1
*P < 0.05 v.s. normal group. ARS, asthma-related symptoms; IQR, interquartile range.
and other indicators of asthma control (asthma attack
rate, frequency of asthma-related symptoms in the
morning and at night, and rate of sleep disturbance
during the two weeks prior to answering the survey)
in the 2008 and 2010 surveys are shown in Table 3A,
B, respectively. In both surveys, the ACT score in the
underweight group was significantly lower than that
in the normal weight group. There were no signifi-
cant differences in the other indicators between the
normal and underweight groups. In both surveys,
there were no significant differences between the
normal and underweight groups in the rate of asthma
Effect of Underweight on Asthma Control
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Table　4A　Asthma attacks and asthma-related work absences during the one year prior to answering the 2008 survey
Table　4B　Asthma attacks and asthma-related work absences during the one year prior to answering the 2010 survey
Normal group (N = 1464) Underweight group (N = 174)
AA: frequent/seasonal/few (%) 129/500/681 (8.8/31.1/46.5) 19/66/76 (10.9/37.9/43.7)
ARWA rate (%) 8.6 12.6
AA, asthma attacks; ARWA, asthma-related work or school absences.
Normal group (N = 1260) Underweight group (N = 155)
AA: frequent/seasonal/few (%) 113/355/670 (9.0/28.2/53.2) 16/52/71 (10.9/33.5/48.5)
ARWA rate (%) 7.8 12.9*
*P < 0.05 v.s. normal group. AA, asthma attacks; ARWA, asthma-related work or school absences.
Table　5A　Drugs/medications in 2008 survey
Table　5B　Drugs/medications in 2010 survey
Normal group (N = 1464) Underweight group (N = 174)
ICS use rate (%) 87.0 83.9
LTRA use rate (%) 40.8 40.9
OCS use rate (%)  4.8  4.0
SML use rate (%) 35.8 37.4
p-TBL use: rate (%)  8.5 10.9
OSRT use: rate (%) 41.4 46.0
ICS, inhaled corticosteroid; LTRA, leukotriene receptor antagonist; OCS, oral corticosteroid; PSL, predonisolone; SML, salmeterol; p-TBL, 
tulobuterol patches; OSRT, oral sustained-released theophylline.
Normal group (N = 1260) Underweight group (N = 155)
ICS use rate (%) 89.3 88.4
LTRA use rate (%) 42.9 38.7
OCS use rate (%)  4.0  5.8
SML use rate (%) 45.6 39.3
p-TBL use: rate (%)  5.2  4.5
OSRT use: rate (%) 36.7 30.3
ICS, inhaled corticosteroid; LTRA, leukotriene receptor antagonist; OCS, oral corticosteroid; PSL, predonisolone; SML, salmeterol; p-TBL, 
tulobuterol patches; OSRT, oral sustained-released theophylline.
attacks during the year prior to answering the survey
(Table 4A, B). In the 2010 survey, the rate of asthma-
related work absences during the year prior to an-
swering the survey in the underweight group was sig-
nificantly higher than that in the normal group, al-
though there was no significant difference in the 2008
survey (Table 4A, B).
DRUGSMEDICATIONS AND SATISFACTION IN
DAILY LIFE
The drugsmedications used by patients, and their
levels of satisfaction with daily life, in the 2008 and
2010 surveys, are summarized in Table 5A, B, 6A, B,
respectively. There were no significant differences in
either the drugsmedications or satisfaction with
daily life, between the normal and underweight
groups in the two surveys.
HOSPITALIZATION, AMBULANCE USE OR
EMERGENCY DEPARTMENT (ED) VISITS, AT-
TACKS WITH UNCONSCIOUSNESS, MECHANI-
CAL VENTILATION AND ASPIRIN INTOLERANT
ASTHMA (AIA) ATTACKS
Table 7A, B, show the rates of hospitalization, ambu-
lance use or ED visits, attacks with unconsciousness,
mechanical ventilation and AIA attacks experienced
in the 2008 and 2010 surveys. There were no signifi-
cant differences in these rates between the normal
and underweight groups in either survey.
MULTIPLE REGRESSION ANALYSIS FOR THE
ACT SCORE
The multiple regression analysis for the ACT score
2008 using age (mean or not), gender (male or fe-
male), disease duration (mean or not), smoking
status (non-, ex- or current smoker), use of peak flow
Furukawa T et al.
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Table　6A　Satisfaction with daily life in 2008 survey
Table　6B　Satisfaction with daily life in 2010 survey
Very satisfi ed/Fairly satisfi ed/Mediocre/Slightly dissatisfi ed/Dissatisfi ed (%)
Normal group (N = 1464) 289/866/175/105/23 (19.6/59.2/12.9/7.2/1.6)
Underweight group (N = 174) 25/99/30/15/4 (14.4/59.6/17.2/8.6/2.3)
Very satisfi ed/Fairly satisfi ed/Mediocre/Slightly dissatisfi ed/Dissatisfi ed (%)
Normal group (N = 1260) 365/649/123/80/19 (29.0/51.5/9.8/6.3/1.5)
Underweight group (N = 155) 41/80/19/10/1 (26.5/51.8/12.3/6.5/0.6)
Table　7A　Hospitalization, ambulance use or ED visits, attacks with unconsciousness, mechanical ventilation and AIA attacks 
in 2008 survey
Table　7B　Hospitalization, ambulance use or ED visits, attacks with unconsciousness, mechanical ventilation and AIA attacks 
in 2010 survey
Normal group (N = 1464) Underweight group (N = 174)
Hospitalization rate (%) 34.8 42.0
Ambulance use or ED visits rate (%) 32.0 37.4
Attacks with unconsciousness rate (%)  6.6  6.9
Mechanical ventilation rate (%)  5.7  5.2
AIA attacks rate (%)  7.1  3.4
ED, emergency department; AIA, aspirin intolerant asthma.
Normal group (N = 1260) Underweight group (N = 155)
Hospitalization rate (%) 33.4 35.5
Ambulance use or ED visits rate (%) 31.0 32.3
Attacks with unconsciousness rate (%)  4.9  1.9
Mechanical ventilation rate (%)  5.0  3.2
AIA attacks rate (%)  6.7  9.7
ED, emergency department; AIA, aspirin intolerant asthma.
meter (use or not) and BMI (underweight or normal)
as independent variables from the data 2008 were
performed. The standard coefficient of regression of
age, gender, disease duration, smoking status, use of
PEFM and BMI in 2008 data were 0.088 (p = 0.001),
0.017 (p = 0.562), 0.065 (p = 0.013), 0.086 (p = 0.004),
0.087 (p = 0.001) and 0.069 (p = 0.008), respectively,
and those in 2010 data were 0.057 (p = 0.053), 0.088
(p = 0.007), 0.092 (p = 0.002), 0.214 (p < 0.001), 0.067
(p = 0.022) and 0.085 (p = 0.004), respectively.
DISCUSSION
The aim of this study was to investigate the influence
of underweight on asthma control in a clinical setting.
Using the JASSO definitions, an underweight group
of asthmatic patients (BMI < 18.5 kgm2) was com-
pared to a normal weight group of asthmatics (18.5
kgm2BMI < 25 kgm2). The results from the 2008
survey showed that compared to those of normal
weight, there were adverse effects on asthma control
from both obesity and underweight. We have previ-
ously reported the relationship between obesity and
asthma control,13 however, based on the 2008 find-
ings, we wanted to re-confirm the apparent effect of
underweight on asthma control because of the pau-
city of published studies to support this result. There-
fore, we decided to repeat the same study using 2010
survey data.
The results clearly indicate that there is an associa-
tion between underweight and asthma. The ACT
scores (Table 3A, B), a reliable indicator for asthma
control, clearly show that asthma control in the un-
derweight group was worse than that in the normal
weight group. Results regarding the frequency of
asthma symptoms and attacks (Table 3, 4), also sug-
gest that asthma control in the underweight group
was worse than in the normal weight group, although
this difference was not statistically significant. In
2010, the rate of asthma-related work absences dur-
ing the year prior to the survey revealed the same
findings as the ACT score. With regard to other fac-
tors such as personal characteristics or medication,
which could potentially influence asthma control,
there were no differences between the normal and
Effect of Underweight on Asthma Control
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underweight groups. Taking all of this into account,
we consider that this study confirms that under-
weight does adversely affect asthma control. How-
ever, the multiple regression analysis indicated that
there were other known factors such as the peak flow
meter use, which influenced the ACT score in this
study. An important point was that the underweight
was a new effector on asthma control.
As mentioned before, the association between un-
derweight and asthma incidence has been well stud-
ied.14-20 These studies showed a U-shape relationship
between the incidence of asthma and BMI, meaning
there is an adverse effect not only of overweight but
also of underweight in relation to the incidence of
asthma in children and adults. In contrast, there have
been very few published reports about the effects of
underweight on asthma control. Although Schachter
et al. found that underweight was associated with a
decreased forced expiratory volume in 1 second and
enhanced airway responsiveness,16 the patients stud-
ied were not asthmatics but normal subjects. There-
fore, our results appear to be the first evidence of a
relationship between underweight and asthma con-
trol in adult asthmatics. Combining our present study
with our previous paper on asthma and overweight,13
it would appear that the influence of BMI on asthma
control is similar to its influence on asthma incidence.
There were some differences between the 2008
and 2010 survey data. In the 2010 survey data, fe-
males were more common in the underweight group
than in the normal group, which was not the case in
the 2008 survey. However, the multiple regression
analysis using 2010 data indicated that this gender
difference is unlikely to influence the results of our
study. We found no significant differences between
the underweight and normal weight groups in rela-
tion to satisfaction with daily life, hospitalizations, am-
bulance use or ED presentation, attacks with uncon-
sciousness, mechanical ventilation or AIA attacks
(Table 6, 7). The reason for this might be that the dif-
ference in asthma control between the normal and
the underweight group was not so large as to affect
these less common outcomes.
The mechanism for the adverse effect of under-
weight on asthma control remains unknown. En-
hanced airway responsiveness and narrowing of the
bronchi might play a role.16 However, these mecha-
nisms themselves are also not well understood. In
COPD, physical capacity, systemic inflammation and
nutritional status have been reported to play impor-
tant roles in the reduction of respiratory function,34
and nutritional status may similarly contribute to the
underweight effect found in our study. In under-
weight subjects with anorexia nervosa or with gastro-
intestinal impairment from abdominal surgery for ma-
lignancy, respiratory muscle impairment has also
been reported.35,36 Although it is still unclear, these
findings suggest that respiratory muscle weakness
might be a potential mechanism to explain the asso-
ciation between underweight and asthma control.
In summary, we have attempted to elucidate the in-
fluence of underweight on asthma control by compar-
ing indicators for asthma control in underweight asth-
matic patients with asthmatic patients of normal BMI,
using data obtained from questionnaire surveys. Us-
ing the Japanese definition of obesity, we found lower
ACT scores in the underweight patients. We con-
clude that there is an association between under-
weight and asthma control in the clinical setting in Ja-
pan. A mechanism of interaction between asthma and
underweight was completely unknown, and further
investigation will be required.
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